Literature DB >> 1656599

Functional analysis of long terminal repeats derived from four strains of simian immunodeficiency virus SIVAGM in relation to other primate lentiviruses.

J Sakuragi1, M Fukasawa, R Shibata, H Sakai, M Kawamura, H Akari, T Kiyomasu, A Ishimoto, M Hayami, A Adachi.   

Abstract

The promoter activity of long terminal repeats (LTRs) of four strains of the simian immunodeficiency virus isolated from African green monkeys (SIVAGM) was compared with those of various LTRs derived from the other representative primate lentiviruses: human immunodeficiency virus type 1 (HIV-1), type 2 (HIV-2), SIV from a rhesus monkey (SIVMAC), and SIV from a mandrill (SIVMND). The expression of the LTRs was evaluated by monitoring chloramphenicol acetyltransferase production after transfection of reporter plasmid clones. In the absence of viral tat, all SIVAGM LTRs acted as much more efficient promoters than any of the other LTRs. When tat gene products were supplied in trans, LTRs of SIVAGM and SIVMND were activated inefficiently relative to high responder LTRs of HIV-2 and SIVMAC. The LTR of HIV-1 was highly activated by HIV-1 tat, but not so much by HIV-2, SIVAGM, and SIVMND tat.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1656599     DOI: 10.1016/0042-6822(91)90798-g

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  10 in total

1.  Stabilization of the U5-leader stem in the HIV-1 RNA genome affects initiation and elongation of reverse transcription.

Authors:  N Beerens; F Groot; B Berkhout
Journal:  Nucleic Acids Res       Date:  2000-11-01       Impact factor: 16.971

2.  Genetic characterization of simian immunodeficiency virus isolated from an African mandrill.

Authors:  H Sakai; J Sakuragi; S Sakuragi; R Shibata; M Hayami; A Ishimoto; A Adachi
Journal:  Arch Virol       Date:  1992       Impact factor: 2.574

3.  Functional analysis of simian immunodeficiency virus SIVAGM long terminal repeat.

Authors:  J Sakuragi; S Sakuragi; S Ueda; A Adachi
Journal:  Virus Genes       Date:  1996       Impact factor: 2.332

4.  A conserved hairpin motif in the R-U5 region of the human immunodeficiency virus type 1 RNA genome is essential for replication.

Authors:  A T Das; B Klaver; B I Klasens; J L van Wamel; B Berkhout
Journal:  J Virol       Date:  1997-03       Impact factor: 5.103

5.  The regulation of primate immunodeficiency virus infectivity by Vif is cell species restricted: a role for Vif in determining virus host range and cross-species transmission.

Authors:  J H Simon; D L Miller; R A Fouchier; M A Soares; K W Peden; M H Malim
Journal:  EMBO J       Date:  1998-08-10       Impact factor: 11.598

6.  Identification of a replication-competent pathogenic human immunodeficiency virus type 1 with a duplication in the TCF-1alpha region but lacking NF-kappaB binding sites.

Authors:  L Zhang; Y Huang; H Yuan; B K Chen; J Ip; D D Ho
Journal:  J Virol       Date:  1997-02       Impact factor: 5.103

7.  Regulatory genes of simian immunodeficiency viruses from west African green monkeys (Cercopithecus aethiops sabaeus).

Authors:  V Jubier-Maurin; P Sarni-Manchado; F Veas; N Vidal; F Bibollet-Ruche; J P Durand; A Galat-Luong; G Cuny
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

8.  Identification of transactivation-response sequences in the long terminal repeat of bovine immunodeficiency-like virus.

Authors:  S Carpenter; S A Nadin-Davis; Y Wannemuehler; J A Roth
Journal:  J Virol       Date:  1993-07       Impact factor: 5.103

Review 9.  Compatibility of Tat and Rev transactivators in the primate lentiviruses.

Authors:  H Sakai; J Sakuragi; S Sakuragi; M Kawamura; A Adachi
Journal:  Arch Virol       Date:  1993       Impact factor: 2.574

10.  Mosaic genome structure of simian immunodeficiency virus from west African green monkeys.

Authors:  M J Jin; H Hui; D L Robertson; M C Müller; F Barré-Sinoussi; V M Hirsch; J S Allan; G M Shaw; P M Sharp; B H Hahn
Journal:  EMBO J       Date:  1994-06-15       Impact factor: 11.598

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.